Quantum-Si, Inc. (QSI)
1.40
+0.18
(+14.75%)
USD |
NASDAQ |
Oct 09, 09:41
Quantum-Si Enterprise Value : 158.55M for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 158.55M |
| October 07, 2026 | 171.68M |
| October 06, 2026 | 158.55M |
| October 05, 2026 | 171.68M |
| October 02, 2026 | 230.78M |
| October 01, 2026 | 204.52M |
| September 30, 2026 | 125.72M |
| September 29, 2026 | 101.22M |
| September 28, 2026 | 65.52M |
| September 25, 2026 | 74.13M |
| September 24, 2026 | 63.34M |
| September 23, 2026 | 57.58M |
| September 22, 2026 | 63.27M |
| September 21, 2026 | 56.97M |
| September 18, 2026 | 54.60M |
| September 17, 2026 | 60.05M |
| September 16, 2026 | 51.32M |
| September 15, 2026 | 49.11M |
| September 14, 2026 | 50.20M |
| September 11, 2026 | 53.49M |
| September 10, 2026 | 53.29M |
| September 09, 2026 | 55.67M |
| September 08, 2026 | 57.86M |
| September 04, 2026 | 59.18M |
| September 03, 2026 | 58.08M |
| Date | Value |
|---|---|
| September 02, 2026 | 58.08M |
| September 01, 2026 | 57.27M |
| August 31, 2026 | 59.16M |
| August 28, 2026 | 62.24M |
| August 27, 2026 | 67.30M |
| August 26, 2026 | 64.56M |
| August 25, 2026 | 76.97M |
| August 24, 2026 | 59.90M |
| August 21, 2026 | 74.28M |
| August 20, 2026 | 62.24M |
| August 19, 2026 | 60.07M |
| August 18, 2026 | 50.86M |
| August 17, 2026 | 54.41M |
| August 14, 2026 | 53.44M |
| August 13, 2026 | 64.43M |
| August 12, 2026 | 74.81M |
| August 11, 2026 | 71.04M |
| August 10, 2026 | 64.45M |
| August 07, 2026 | 69.77M |
| August 06, 2026 | 56.77M |
| August 05, 2026 | 57.10M |
| August 04, 2026 | 59.05M |
| August 03, 2026 | 54.80M |
| July 31, 2026 | 47.44M |
| July 30, 2026 | 49.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 76.49M |
| Medpace Holdings, Inc. | 16.42B |
| Avantor, Inc. | 13.80B |
| Personalis, Inc. | 1.534B |
| Adaptive Biotechnologies Corp. | 4.224B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.53M |
| Revenue (Quarterly) | 0.344M |
| Total Expenses (Quarterly) | 23.88M |
| EPS Diluted (Quarterly) | -0.108 |
| Gross Profit Margin (Quarterly) | -298.8% |
| Profit Margin (Quarterly) | -6.84K% |
| Earnings Yield | -33.08% |
| Normalized Earnings Yield | -30.01 |